Coya Therapeutics, Inc.
NASDAQ: COYA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Arun Swaminathan
- Employees
- 8
- Headquarters
- Houston, United States
- IPO year
- 2022
- Market cap
- $96.9M
- Website
- https://www.coyatherapeutics.com
Loading COYA…
Loading profile data…Frequently asked questions about COYA
What does Coya Therapeutics, Inc. (COYA) do?
Coya Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative therapeutic agents that fine-tune the function of regulatory T cells (Tregs). Its therapeutic pipeline leverages diverse approaches, including biologics designed to enhance Treg activity, Treg-derived exosomes, and personalized autologous Treg cell...
Where does COYA trade?
Coya Therapeutics, Inc. (COYA) trades on the NASDAQ Capital Market.
What sector is COYA in?
Coya Therapeutics, Inc. (COYA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Coya Therapeutics, Inc.?
Arun Swaminathan is the chief executive officer of Coya Therapeutics, Inc. (COYA).
Where is Coya Therapeutics, Inc. headquartered?
Coya Therapeutics, Inc. is headquartered in United States.
Does COYA pay a dividend?
Coya Therapeutics, Inc. (COYA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did COYA go public?
Coya Therapeutics, Inc. (COYA) completed its initial public offering in 2022.